Global Blood Therapeutics, Inc.
(NASDAQ : GBT)

( )
GBT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.80%69.520.0%$2214.61m
NVAXNovavax, Inc. -16.77%124.4296.5%$1026.77m
SRNESorrento Therapeutics, Inc. -11.92%12.411.5%$731.21m
GILDGilead Sciences, Inc. 1.09%68.841.0%$571.41m
AMGNAmgen, Inc. 3.01%241.721.3%$485.13m
REGNRegeneron Pharmaceuticals, Inc. 2.25%612.352.7%$399.20m
VRTXVertex Pharmaceuticals, Inc. 3.43%270.851.9%$367.43m
BIIBBiogen, Inc. 1.13%293.221.6%$355.55m
BNTXBioNTech SE 0.96%69.110.0%$350.86m
ILMNIllumina, Inc. 0.86%344.143.5%$338.32m
VXRTVaxart, Inc. -14.42%9.200.0%$262.52m
ATNMActinium Pharmaceuticals, Inc. -0.31%9.6313.3%$232.11m
EBSEmergent BioSolutions, Inc. 6.00%129.676.4%$188.23m
ALXNAlexion Pharmaceuticals, Inc. 1.52%102.782.0%$167.84m
SGENSeattle Genetics, Inc. 3.46%158.796.0%$158.72m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.